© 1994-2010 China Academic Journal Electronic Publishing House. All rights reserved. http://www.cnki.net[12]NikolopoulouA,MainaT,SotiriouP,etal.Tetraamine2modifiedoctreotideandoctreotate:labelingwith99mTcandpreclinicalcomparisoninAR422JcellsandAR422Jtumor2bearingmice[J].JPeptSci,2006,12(2):1242131.[13]AntunesP,GinjM,ZhangH,etal.Areradiogallium2labelledDOTA2conjugatedsomatostatinanaloguessuperiortothoselabelledwithotherradiometals[J]?EurJNuclMedMolImaging,2007,34(7):9822993.[14]GinjM,SchmittJS,ChenJ,etal.Design,synthesis,andbiologi2calevaluationofsomatostatin2basedradiopeptides[J].ChemBiol,2006,13(10):108121090.[15]PettinatoC,SarnelliA,DiDonnaM,etal.68Ga2DOTANOC:bio2distributionanddosimetryinpatientsaffectedbyneuroendocrinetumors[J].EurJNuclMedMolImaging,2008,35(1):72279.[16]GinjM,ZhangH,WaserB,etal.Radiolabeledsomatostatinre2ceptorantagonistsarepreferabletoagonistsforinvivopeptidereceptortargetingoftumors[J].ProcNatlAcadSciUSA,2006,103(44):16436216441.[17]Ferro2FloresG,ArteagadeMurphyC,Rodriguez2CortesJ,etal.Preparationandevaluationof99mTc2EDDA/HYNIC2[Lys3]2bombesinforimaginggastrin2releasingpeptidereceptor2positivetumours[J].NuclMedCommun,2006,27(4):3712376.[18]GarciaGarayoaE,RueggD,BlauensteinP,etal.ChemicalandbiologicalcharacterizationofnewRe(CO)3/99mTc(CO)3bombesinana2logues[J].NuclMedBiol,2007,34(1):17228.[19]ZhangH,SchuhmacherJ,WaserB,etal.DOTA2PESIN,aDOTA2conjugatedbombesinderivativedesignedfortheimagingandtarge2tedradionuclidetreatmentofbombesinreceptor2positivetumours[J].EurJNuclMedMolImaging,2007,34(8):119821208.[20]LantryLE,CappellettiE,MaddalenaME,etal.177Lu2AMBA:Synthesisandcharac2terizationofaselective177Lu2labeledGRP2Ragonistforsystemicradiotherapyofprostatecancer[J].JNuclMed,2006,47(7):114421152.[21]BaumR,PrasadV,MutlokaN,etal.Molecularimagingofbombe2sinreceptorsinvarioustumorsbyGa268AMBAPET/CT:firstresults[J].JNuclMed,2007,48(Suppl):79P.[22]MaesV,Garcia2GarayoaE,BlauensteinP,etal.Novel99mTc2la2beledneurotensinanalogueswithoptimizedbiodistributionproperties[J].JMedChem,2006,49(5):183321836.[23]deVisserM,JanssenPJ,SrinivasanA,etal.Stabilised111In2la2belledDTPA2andDOTA2conjugatedneurotensinanaloguesforimagingandtherapyofexocrinepancreaticcancer[J].EurJNuclMedMolImaging,2003,30(8):113421139.[24]BucheggerF,BonvinF,KosinskiM,etal.Radiolabeledneuroten2sinanalog,99mTc2NTXI,evaluatedinductalpancreaticadenocarcinomapatients[J].JNuclMed,2003,44(10):164921654.[25]MatherSJ,McKenzieAJ,SosabowskiJK,etal.Selectionofradio2labeledgastrinanalogsforpeptidereceptor2targetedradionuclidetherapy[J].JNuclMed,2007,48(4):6152622.[26]GotthardtM,BeheMP,BeuterD,etal.Improvedtumourdetectionbygastrinreceptorscintigraphyinpatientswithmetastasisedmedullarythyroidcarcinoma[J].EurJNuclMedMolImaging,2006,33(11):127321279.[27]GotthardtM,BeheMP,GrassJ,etal.Addedvalueofgastrinre2ceptorscintigraphyincomparisontosomatostatinreceptorscintigraphyinpatientswithcarcinoidsandotherneuroendocrinetumours[J].EndocrRelatCancer,2006,13(4):120321211.[28]KornerM,StockliM,WaserB,etal.GLP21Receptorexpressioninhumantumorsandhumannormaltissues:PotentialforInVivoTarge2ting[J].JNuclMed,2007,48(5):7362743.[29]GotthardtM,LalykoG,vanEerd2VismaleJ,etal.Anewtech2niqueforinvivoimagingofspecificGLP21bindingsites:Firstresultsinsmallrodents[J].RegulPept,2006,137(3):1622167.[30]WildD,BeheM,WickiA,etal.[Lys40(Ahx2DTPA2111In)NH2]exendin24,averypromisingligandforglucagon2likepeptide21(GLP21)receptortargeting[J].JNuclMed,2006,47(12):202522033.[31]CaiW,ZhangX,WuY,etal.Athiol2reactive18F2labelingagent,N2[22(4218F2fluorobenzamido)ethyl]maleimide,andsynthesisofRGDpeptide2basedtracerforPETimagingofalphavbeta3integrinexpression[J].JNuclMed,2006,47(7):117221180.[32]DijkgraafI,KruijtzerJA,LiuS,etal.Improvedtargetingoftheal2pha(v)beta(3)integrinbymultimerisationofRGDpeptides[J].EurJNuclMedMolImaging,2007,34(2):2672273.[33]DijkgraafI,LiuS,KruijtzerJA,etal.Effectsoflinkervariationontheinvitroandinvivocharacteristicsofan111In2labeledRGDpeptide[J].NuclMedBiol,2007,34(1):29235.[34]DijkgraafI,KruijtzerJA,FrielinkC,etal.Alphavbeta3integrin2targetingofintraperitoneallygrowingtumorswitharadiolabeledRGDpep2tide[J].IntJCancer,2007,120(3):6052610.[35]deJongM,BreemanWA,BernardBF,etal.Tumorresponseafter90Y2DOTA02Tyr32octreotideradionuclidetherapyinatransplantablerat

tumormodelisdependentontumorsize[J].JNuclMed,2001,42(12):184121846.[36]ReubiJCandWaserB.Concomitantexpressionofseveralpeptidereceptorsinneuroendocrinetumours:molecularbasisforinvivomultire2ceptortumourtargeting[J].EurJNuclMedMolImaging,2003,30(5):7812793.(2010-02-26收稿)